BC
ORGO icon

Barrett & Company’s Organogenesis Holdings ORGO Stock Holding History

Barrett & Company’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,100
Closed -$3.12K – 618
2024
Q1 		$3.12K Hold
1,100
– – ﹤0.01% 523
2023
Q4 		$4.5K Hold
1,100
– – ﹤0.01% 480
2023
Q3 		$3.5K Sell
1,100
-6,700
-86% -$21.3K ﹤0.01% 510
2023
Q2 		$25.9K Hold
7,800
– – 0.02% 316
2023
Q1 		$16.6K Hold
7,800
– – 0.01% 345
2022
Q4 		$21K Hold
7,800
– – 0.01% 310
2022
Q3 		$21K Buy
+7,800
New +$35.2K 0.01% 310

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrett & Company's ORGO Position: Q2 2024 in Review

Barrett & Company sold out of Organogenesis Holdings (ORGO) in Q2 2024, closing a stake of 1,100 shares — an estimated $3.12K sold.

Barrett & Company first reported a position in ORGO in Q3 2022 and held it in 7 quarters. The position peaked at $25.9K in Q2 2023. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2024.

  • Barrett & Company reported no remaining Organogenesis Holdings position as of Q2 2024 after selling out during the quarter.
  • Barrett & Company sold 1,100 Organogenesis Holdings shares in Q2 2024, an estimated $3.12K.
  • Barrett & Company first reported a position in Organogenesis Holdings in Q3 2022 and held it in 7 quarters.
  • Barrett & Company's Organogenesis Holdings position peaked at $25.9K in Q2 2023.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2024.

Based on Barrett & Company's 13F filing for Q2 2024, filed 25 Jul 2024.